Skip to content

Reaching and Engaging Depressed Senior Center Clients

Reaching and Engaging Depressed Senior Center Clients Phase II

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04289298
Acronym
REDS II
Enrollment
26
Registered
2020-02-28
Start date
2020-09-03
Completion date
2022-08-31
Last updated
2023-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression in Old Age

Keywords

depression, geriatric, psychotherapy, group

Brief summary

The purpose of this study is to test the feasibility of one type of therapy session, Virtual Augmented Engage (Engage-A). The research is being done because the researchers are trying to learn if these approaches could be used by therapists in the community social service agencies to treat older adults with depression. The research will also measure clinician satisfaction after training and supervision of utilization of Engage-A.

Interventions

BEHAVIORALEngage-A

Therapist will encourage participants to engage in physical and social activities that are pleasurable or rewarding. Engage is a stepped care psychotherapy based on what is known about how older adults respond to depression interventions. Stepped care is a model of treatment that starts with the minimum effective therapeutic techniques first, and then based on how well people respond to treatment, additional therapeutic techniques are added until people are recovered from their depression.

OTHERTraining and utilizing Engage-A therapy

Therapist will be trained in Engage-A therapy and given supervision while utilizing this therapy.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 55 years' old * PHQ-9 Score of ≥ 10 * English or Spanish speaking * MOCA ≥ 24 or mini-telephone MOCA ≥ 11 * Member of/attends one of the REDS Senior Centers * Capacity to provide written consent for both research assessment and the Engage-A intervention.

Exclusion criteria

* Current active suicidal ideation defined by MADRS Suicide Item ≥ 4 (probably better off dead. Suicidal thoughts are common, and suicide is considered as a possible solution, but without specific plans or intention). * Presence of psychiatric diagnoses other than unipolar, non-psychotic major depression or generalized anxiety disorder by SCID-IV. * Severe or life-threatening medical illness (e.g., end stage organ failure). * Currently seeing an individual psychotherapist \*(if individuals are willing to go on a hiatus from their individual psychotherapist for the 15 weeks of the study, and meet all inclusion criteria, they will be considered eligible).

Design outcomes

Primary

MeasureTime frameDescription
Number of Virtual ENGAGE-A Participants Who Attend Every Scheduled Therapy Session9 WeeksNumber of Virtual ENGAGE-A Participants who Attend Every Scheduled Therapy Session
Change in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQ6 weeks, 9 weeks, 12 weeksThe Client Satisfaction Questionnaire (CSQ) assesses the clients' satisfaction with the services they are receiving. The CSQ ranges from 1-4, with higher scores indicating higher satisfaction. Domain 1 scores range from 1-4, with higher scores indicating higher satisfaction with the program. Domain 2 scores range from 1-4, with higher scores indicating higher satisfaction with the services received. Domain 3 scores range from 1-4, with higher scores indicating higher likelihood of wanting to receive similar services in the future. Higher scores for all three domains indicate a better outcome.
Average Satisfaction Score of Community Clinicians (LCSW) as Measured by the TSQ2 yearsThe Therapist Satisfaction Questionnaire (TSQ) assesses the therapists' satisfaction with the Alacrity therapy training and intervention. The TSQ ranges from 1-4, with higher scores indicating higher satisfaction. Domain 1 scores range from 1-4, with higher scores indicating higher satisfaction with the skills obtained through training. Domain 2 scores range from 1-4, with higher scores indicating higher satisfaction with the therapy type. Domain 3 scores range from 1-4, with higher scores indicating higher likelihood that the therapist would use this therapy in their own practice. Higher scores for all three domains indicate better outcomes.

Secondary

MeasureTime frameDescription
Change in Depressive Symptoms of Virtual ENGAGE-A Participants as Measured by HAM-DBaseline, 6 week, 9 week, 12 weekHamilton Depression Rating Score (HAM-D) assesses the severity of depression in patients. The HAM-D ranges from 0 to 52, with higher scores indicating higher severity of depression.
Change in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSBaseline, 6 week, 9 week, 12 weekThe Behavioral Activation for Depression Scale (BADS) measures levels of behavioral activation. The BADS ranges from 0 to 150, with higher scores indicating lower levels of behavioral activation. Domain 1 scores range from 0-42. Higher scores (better outcome) indicate greater activation. Domain 2 scores range from 0-48. Higher scores (worse outcome) indicate greater Avoidance and Rumination. Domain 3 scores range from 0-30. Higher scores (worse outcome) indicate greater Work/School impairment. Domain 4 scores range from 0-30. Higher scores (worse outcome) indicate greater social impairment.

Countries

United States

Participant flow

Participants by arm

ArmCount
Engage-A
Participants receive 9 individual in-person or remote therapy sessions. Each session will last approximately 60 minutes. During the sessions, the therapist will encourage the participant to engage in physical and social activities that are pleasurable or rewarding. Engage-A: Therapist will encourage participants to engage in physical and social activities that are pleasurable or rewarding. Engage is a stepped care psychotherapy based on what is known about how older adults respond to depression interventions. Stepped care is a model of treatment that starts with the minimum effective therapeutic techniques first, and then based on how well people respond to treatment, additional therapeutic techniques are added until people are recovered from their depression.
22
Clinician Participants
Clinicians who provided the ENGAGE intervention and participated in data collection about their experience.
4
Total26

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up50
Overall StudyWithdrawal by Subject20

Baseline characteristics

CharacteristicTotalEngage-AClinician Participants
Age, Continuous66.68 years
STANDARD_DEVIATION 6.53
66.68 years
STANDARD_DEVIATION 6.53
48.5 years
STANDARD_DEVIATION 10.43
Behavioral Activation for Depression Scale (BADS)
Domain 1, Baseline
18.62 units on a scale
STANDARD_DEVIATION 10.22
18.62 units on a scale
STANDARD_DEVIATION 10.22
Behavioral Activation for Depression Scale (BADS)
Domain 2, Baseline
22.50 units on a scale
STANDARD_DEVIATION 8.61
22.50 units on a scale
STANDARD_DEVIATION 8.61
Behavioral Activation for Depression Scale (BADS)
Domain 3, Baseline
13.76 units on a scale
STANDARD_DEVIATION 6.77
13.76 units on a scale
STANDARD_DEVIATION 6.77
Behavioral Activation for Depression Scale (BADS)
Domain 4, Baseline
20.25 units on a scale
STANDARD_DEVIATION 6.91
20.25 units on a scale
STANDARD_DEVIATION 6.91
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants3 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
21 Participants19 Participants2 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Hamilton Psychiatric Rating Scale for Depression (HAM-D)21.28 units on a scale
STANDARD_DEVIATION 5.6
21.28 units on a scale
STANDARD_DEVIATION 5.6
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
3 Participants3 Participants0 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
22 Participants18 Participants4 Participants
Region of Enrollment
United States
26 participants22 participants4 participants
Sex: Female, Male
Female
24 Participants20 Participants4 Participants
Sex: Female, Male
Male
2 Participants2 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 220 / 0
other
Total, other adverse events
0 / 220 / 0
serious
Total, serious adverse events
0 / 220 / 0

Outcome results

Primary

Average Satisfaction Score of Community Clinicians (LCSW) as Measured by the TSQ

The Therapist Satisfaction Questionnaire (TSQ) assesses the therapists' satisfaction with the Alacrity therapy training and intervention. The TSQ ranges from 1-4, with higher scores indicating higher satisfaction. Domain 1 scores range from 1-4, with higher scores indicating higher satisfaction with the skills obtained through training. Domain 2 scores range from 1-4, with higher scores indicating higher satisfaction with the therapy type. Domain 3 scores range from 1-4, with higher scores indicating higher likelihood that the therapist would use this therapy in their own practice. Higher scores for all three domains indicate better outcomes.

Time frame: 2 years

Population: Engage-A participants were not analyzed as part of this measure as it does not apply to them.

ArmMeasureGroupValue (MEAN)Dispersion
Clinician ParticipantsAverage Satisfaction Score of Community Clinicians (LCSW) as Measured by the TSQDomain 14.0 units on a scaleStandard Deviation 0
Clinician ParticipantsAverage Satisfaction Score of Community Clinicians (LCSW) as Measured by the TSQDomain 24.0 units on a scaleStandard Deviation 0
Clinician ParticipantsAverage Satisfaction Score of Community Clinicians (LCSW) as Measured by the TSQDomain 34.0 units on a scaleStandard Deviation 0
Primary

Change in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQ

The Client Satisfaction Questionnaire (CSQ) assesses the clients' satisfaction with the services they are receiving. The CSQ ranges from 1-4, with higher scores indicating higher satisfaction. Domain 1 scores range from 1-4, with higher scores indicating higher satisfaction with the program. Domain 2 scores range from 1-4, with higher scores indicating higher satisfaction with the services received. Domain 3 scores range from 1-4, with higher scores indicating higher likelihood of wanting to receive similar services in the future. Higher scores for all three domains indicate a better outcome.

Time frame: 6 weeks, 9 weeks, 12 weeks

Population: The number of participants analyzed at week 6 was 18, at week 9 was 16, and at week 12 was 15 due to loss to follow up and participant withdrawal.~Clinician Participants were not analyzed for this measure as it does not apply to them.

ArmMeasureGroupValue (MEAN)Dispersion
Engage-AChange in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQDomain 2- week 62.89 units on a scaleStandard Deviation 0.76
Engage-AChange in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQDomain 2- week 93.31 units on a scaleStandard Deviation 0.79
Engage-AChange in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQDomain 1- week 62.5 units on a scaleStandard Deviation 0.62
Engage-AChange in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQDomain 3- week 62.83 units on a scaleStandard Deviation 0.79
Engage-AChange in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQDomain 1- week 92.5 units on a scaleStandard Deviation 0.63
Engage-AChange in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQDomain 3- week 93.33 units on a scaleStandard Deviation 0.9
Engage-AChange in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQDomain 1- week 122.73 units on a scaleStandard Deviation 0.88
Engage-AChange in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQDomain 2- week 123.40 units on a scaleStandard Deviation 0.74
Engage-AChange in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQDomain 3- week 123.27 units on a scaleStandard Deviation 0.88
Primary

Number of Virtual ENGAGE-A Participants Who Attend Every Scheduled Therapy Session

Number of Virtual ENGAGE-A Participants who Attend Every Scheduled Therapy Session

Time frame: 9 Weeks

Population: The total number of participants that completed all scheduled therapy sessions at week 9. The number of participants analyzed at week 9 for this measure (17) is higher than the number analyzed for the other measures at week 9 (16) because one participant attended the week 9 therapy session but left the study before having completed the week 9 assessment, during which the remaining measures are completed.~Clinician Participants were not analyzed for this measure as it does not apply to them.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Engage-ANumber of Virtual ENGAGE-A Participants Who Attend Every Scheduled Therapy Session17 Participants
Secondary

Change in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADS

The Behavioral Activation for Depression Scale (BADS) measures levels of behavioral activation. The BADS ranges from 0 to 150, with higher scores indicating lower levels of behavioral activation. Domain 1 scores range from 0-42. Higher scores (better outcome) indicate greater activation. Domain 2 scores range from 0-48. Higher scores (worse outcome) indicate greater Avoidance and Rumination. Domain 3 scores range from 0-30. Higher scores (worse outcome) indicate greater Work/School impairment. Domain 4 scores range from 0-30. Higher scores (worse outcome) indicate greater social impairment.

Time frame: Baseline, 6 week, 9 week, 12 week

Population: The number of participants analyzed was 21 at baseline, 18 at week 6, 16 at week 9, and 15 at week 12.~Clinician Participants were not analyzed for this measure as it does not apply to them.

ArmMeasureGroupValue (MEAN)Dispersion
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 1, Baseline18.62 units on a scaleStandard Deviation 10.22
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 2, Baseline22.50 units on a scaleStandard Deviation 8.61
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 3, Baseline13.76 units on a scaleStandard Deviation 6.77
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 4, Baseline20.25 units on a scaleStandard Deviation 6.91
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 1, Week 624.67 units on a scaleStandard Deviation 7.58
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 2, Week 627.94 units on a scaleStandard Deviation 8.77
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 3, Week 616.61 units on a scaleStandard Deviation 7.16
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 4, Week 622.0 units on a scaleStandard Deviation 7.23
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 1, Week 927.94 units on a scaleStandard Deviation 7.03
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 2, Week 930.19 units on a scaleStandard Deviation 11.23
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 3, Week 920.19 units on a scaleStandard Deviation 5.55
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 4, Week 923.88 units on a scaleStandard Deviation 5.89
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 1, Week 1224.40 units on a scaleStandard Deviation 10.22
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 2, Week 1231.33 units on a scaleStandard Deviation 12.83
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 3, Week 1221.47 units on a scaleStandard Deviation 7.61
Engage-AChange in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADSDomain 4, Week 1223.93 units on a scaleStandard Deviation 8.24
Secondary

Change in Depressive Symptoms of Virtual ENGAGE-A Participants as Measured by HAM-D

Hamilton Depression Rating Score (HAM-D) assesses the severity of depression in patients. The HAM-D ranges from 0 to 52, with higher scores indicating higher severity of depression.

Time frame: Baseline, 6 week, 9 week, 12 week

Population: The total number of participants analyzed was 18 at baseline, 18 at week 6, 16 at week 9, and 15 and week 12 due to participant withdrawal and loss to follow-up.~Clinician Participants were not analyzed for this measure as it does not apply to them.

ArmMeasureGroupValue (MEAN)Dispersion
Engage-AChange in Depressive Symptoms of Virtual ENGAGE-A Participants as Measured by HAM-DWeek 1211.67 units on a scaleStandard Deviation 6.72
Engage-AChange in Depressive Symptoms of Virtual ENGAGE-A Participants as Measured by HAM-DBaseline21.24 units on a scaleStandard Deviation 5.77
Engage-AChange in Depressive Symptoms of Virtual ENGAGE-A Participants as Measured by HAM-DWeek 614.47 units on a scaleStandard Deviation 5.49
Engage-AChange in Depressive Symptoms of Virtual ENGAGE-A Participants as Measured by HAM-DWeek 911.19 units on a scaleStandard Deviation 5.65

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026